Feifan Yao
机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing Medical University
发表论文 3 篇 · 总被引 119 次 · h-index 3
代表论文
- Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners (2023 · Cell Metabolism · 被引 53)
- CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma (2024 · Cancer Letters · 被引 36)
- eIF3f promotes tumour malignancy by remodelling fatty acid biosynthesis in hepatocellular carcinoma (2025 · Journal of Hepatology · 被引 30)